Author: Jieun Choe
Certara 推出了 Pinnacle 21™ Enterprise 的更新和全新的 Pinnacle 21™ Data Exchange 模块
New automation, analytics and collaboration features save time and ensure regulatory compliance PRINCETON, N.J., August 5 — Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation, today announced the feature release 5.2.0 of Pinnacle 21 Enterprise, the Company’s flagship software for validating clinical trial data for biosimulation and regulatory submissions. It also introduced the new … Continued
Certara and Chemaxon Announce Collaboration in Scientific Informatics Software
PRINCETON, N.J., 2022 年 4 月 26 日 — Certara, Inc., a global leader in biosimulation, and Chemaxon, a leading chemical and biological software development company, today announced a strategic partnership to accelerate drug discovery research through integrated scientific informatic workflows to modernize pharmaceutical research. This partnership provides interconnectivity between Certara’s D360 Scientific Informatics software and Chemaxon’s Design … Continued
Certara 宣布公开发行普通股的定价
PRINCETON, N.J., 2021 年 11 月 17 日. — Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation, today announced the pricing of its underwritten public offering of 10 million shares of its common stock by certain existing stockholders (the “selling stockholders”) at a price to the public of $31.00 per share. Additionally, the selling stockholders have granted the underwriters … Continued
Certara 宣布拟公开发行普通股
PRINCETON, N.J.– 2021 年 11 月 15 日– Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation, today announced a proposed underwritten public offering by certain selling stockholders of 10 million shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Additionally, the selling stockholders intend to grant the underwriters a … Continued
Certara Appoints Patrick F. Smith to President of Integrated Drug Development
Princeton, N.J., 2021 年 10 月 12 日 – Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation, today announced the appointment of Patrick F. Smith, Pharm.D. as president of Integrated Drug Development (IDD), reporting to CEO William F. Feehery. Dr. Smith will lead the Company’s global drug development services team, which creates value for clients across the … Continued
FDA Submission Readiness Services
Pinnacle 21 Enterprise
Pinnacle 21 Define.xml 2.0 设计器
Certara 宣布拟公开发行普通股
PRINCETON, N.J.—2021 年 9 月 3 日. 全球生物模拟科技行业巨头 Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation, today announced a proposed underwritten public offering of 20,000,000 shares of its common stock pursuant to a registration statement filed with the Securities and Exchange Commission. Certara is offering 4,500,000 shares of common stock and certain selling stockholders are offering 15,500,000 shares … Continued
